We are honoured to announce that Dan Baker is the new project lead of the Rheuma Tolerance for Cure project. Dan is Vice President of immunology R&D at Janssen Pharmaceutica, and he is thrilled to become part of this IMI2 project.
“I am thrilled to have the opportunity to be so closely involved in this important project that will provide solutions transformational for patients with RA and other immune based diseases.”
We say goodbye to our former project lead, Anish Suri and thank him for all the time and effort that he has put into this project. Anish has left Janssen Pharmaceutica to take up an exciting role at Cue Biopharma. He is appointed as Senior Vice President and Chief Scientific Officer of this innovative company focusing on immunotherapy. For more information about this company, you can have a look at their website: https://www.cuebiopharma.com/.
We would like to thank Anish for his support, and to welcome Dan to the team!
We wish you both good luck with your new adventures!
